Kymera Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11/14/2025 | 6.65 M | $376.47 M | 0.00% | 7.62% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 6.35 M | $359.41 M | -3.14% | 7.27% |
| FMR LLC | 11/13/2025 | 5.88 M | $332.79 M | 8.24% | 6.73% |
| BVF INC/IL | 11/14/2025 | 5.50 M | $311.45 M | 0.00% | 6.30% |
| VANGUARD GROUP INC | 11/07/2025 | 5.42 M | $306.87 M | -3.53% | 6.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 5.20 M | $294.08 M | -3.28% | 5.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 5.10 M | $288.51 M | -25.69% | 5.84% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2025 | 4.90 M | $277.14 M | 0.00% | 5.61% |
| BLACKROCK, INC. | 11/12/2025 | 4.37 M | $247.08 M | 5.24% | 5.00% |
| SIREN, L.L.C. | 11/13/2025 | 3.43 M | $194.03 M | 0.00% | 3.93% |
| STATE STREET CORP | 11/14/2025 | 2.02 M | $114.30 M | 29.92% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.28 M | $72.28 M | 7.01% | 1.46% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2025 | 1.26 M | $71.44 M | 0.00% | 1.45% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 1.03 M | $58.17 M | 24.57% | 1.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 939.09 K | $53.15 M | 0.56% | 1.08% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 863.76 K | $48.89 M | 5.47% | 0.99% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 840.33 K | $47.56 M | 100.00% | 0.96% |
| MERCK & CO., INC. | 11/12/2025 | 772.17 K | $43.70 M | 0.00% | 0.88% |
| COMMODORE CAPITAL LP | 11/14/2025 | 750.00 K | $42.45 M | 0.00% | 0.86% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 731.42 K | $41.41 M | 29.83% | 0.84% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 711.44 K | $40.27 M | 155.24% | 0.81% |
| UBS GROUP AG | 11/13/2025 | 648.72 K | $36.72 M | 16.31% | 0.74% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 644.59 K | $36.48 M | 14.49% | 0.74% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 615.09 K | $34.81 M | 1,130.18% | 0.70% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 611.22 K | $34.60 M | 574.43% | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 572.26 K | $32.39 M | -12.36% | 0.66% |
| FEDERATED HERMES, INC. | 11/03/2025 | 558.70 K | $31.62 M | 100.00% | 0.64% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2025 | 518.06 K | $29.32 M | 5.34% | 0.59% |
| AJU IB INVESTMENT CO., LTD. | 11/06/2025 | 457.06 K | $25.86 M | 0.00% | 0.52% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 450.37 K | $25.49 M | 0.00% | 0.52% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 439.83 K | $24.89 M | 2.45% | 0.50% |
| NORTHERN TRUST CORP | 11/14/2025 | 437.12 K | $24.74 M | 6.78% | 0.50% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 435.01 K | $24.62 M | -10.85% | 0.50% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 429.98 K | $24.34 M | 170.15% | 0.49% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 397.04 K | $22.47 M | 58.82% | 0.45% |
| MORGAN STANLEY | 11/14/2025 | 377.80 K | $21.38 M | 59.00% | 0.43% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 372.40 K | $21.08 M | 66.03% | 0.43% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 360.00 K | $20.38 M | 35.34% | 0.41% |
| MARSHALL WACE, LLP | 11/13/2025 | 359.08 K | $20.32 M | 33.34% | 0.41% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 351.25 K | $19.88 M | 954.03% | 0.40% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 346.82 K | $19.78 M | 6,139.96% | 0.40% |
| NEXTECH INVEST, LTD. | 11/14/2025 | 340.91 K | $19.30 M | 0.00% | 0.39% |
| DEER MANAGEMENT CO. LLC | 11/14/2025 | 325.90 K | $18.45 M | 0.00% | 0.37% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 319.10 K | $18.06 M | -26.14% | 0.37% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 277.73 K | $15.72 M | 100.00% | 0.32% |
| BRAIDWELL LP | 11/14/2025 | 276.69 K | $15.66 M | 100.00% | 0.32% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 250.00 K | $14.15 M | 100.00% | 0.29% |
| WOODLINE PARTNERS LP | 11/14/2025 | 248.00 K | $14.04 M | -50.21% | 0.28% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2025 | 246.70 K | $13.96 M | -25.02% | 0.28% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 238.00 K | $13.47 M | -21.76% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kymera Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 265 institutional investors and hedge funds held shares of Kymera Therapeutics, Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 6.65 M
Avoro Capital Advisors LLC: 6.35 M
FMR LLC: 5.88 M
BVF INC/IL: 5.5 M
VANGUARD GROUP INC: 5.42 M
WELLINGTON MANAGEMENT GROUP LLP: 5.2 M
92.63% of Kymera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 86.76 M shares in the last 24 months. This purchase volume represents approximately $5.02 B in transactions.